首页> 外文期刊>Journal of critical care >Major publications in the critical care pharmacotherapy literature: January–December 2016
【24h】

Major publications in the critical care pharmacotherapy literature: January–December 2016

机译:主要出版物在关键护理药物疗法文献:2016年1月至12月

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Abstract Purpose To summarize select critical care pharmacotherapy guidelines and studies published in 2016. Summary The Critical Care Pharmacotherapy Literature Update (CCPLU) Group screened 31 journals monthly for relevant pharmacotherapy articles and selected 107 articles for review over the course of 2016. Of those included in the monthly CCPLU, three guidelines and seven primary literature studies are reviewed here. The guideline updates included are as follows: hospital-acquired pneumonia and ventilator-associated pneumonia management, sustained neuromuscular blocking agent use, and reversal of antithrombotics in intracranial hemorrhage (ICH). The primary literature summaries evaluate the following: dexmedetomidine for delirium prevention in post-cardiac surgery, dexmedetomidine for delirium management in mechanically ventilated patients, high-dose epoetin alfa after out-of-hospital cardiac arrest, ideal blood pressure targets in ICH, hydrocortisone in severe sepsis, procalcitonin-guided antibiotic de-escalation, and empiric micafungin therapy. Conclusion The review provides a synopsis of select pharmacotherapy publications in 2016 applicable to clinical practice. Highlights " Reviews pharmacotherapy-focused guidelines (n=3) and studies (n=7) " Articles selected based on applicability, relevance, and strength of study design " Commentary provided by critical care pharmacists on clinical impact
机译:摘要摘要选择关键护理药物治疗指南和研究发表于2016年。摘要关键护理药物治疗文献更新(CCPLU)集团筛选了31份相关药物治疗条款的期刊,并在2016年期间选择了107条审查文章。每月CCPLU,三项指南和七项主要文献研究都在这里进行了审查。包括的指南更新如下:医院获得的肺炎和呼吸机相关的肺炎管理,持续的神经肌肉阻断剂使用,以及颅内出血(ICH)中的抗蛋白质的逆转。主要文献摘要评价以下:德克萨梅托哌咪唑在心脏病后手术后预防,用于机械通风患者的谵妄管理,高剂量Epoetin Alfa,在医院外心脏骤停后,ICH,氢化可源性的理想血压靶标严重的败血症,procalcitonin引导抗生素脱升升级和经验麦克风治疗。结论审查提供了2016年选择药物疗法出版物的概要,适用于临床实践。亮点“评论以药物疗法为中心的指南(N = 3)和基于适用性,相关性和研究设计强度选择的文章,由Critical Care Pharmacitors提供的临床影响提供的评论

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号